Bioventus Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

BVS
Bioventus

Last Price:

11.76

Seasonality Move:

-1.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Bioventus Price Quote

$11.76

+0.05 (+2.17%)

(Updated: November 23, 2024 at 5:28 AM ET)

Bioventus Key Stats

Buy

Bioventus (BVS) is a Buy

Day range:

$11.30 - $11.89

52-week range:

$3.77 - $14.38

Dividend yield:

P/E ratio:

0.00

P/S ratio:

1.35

P/B ratio:

5.15%

Volume:

287.9K

Avg. volume:

434.9K

1-year change:

206.54%

Market cap:

$765.5M

Revenue:

$512.3M

EPS:

$-0.6

How Much Does Bioventus Make?

How Much Are Bioventus's Sales Annually?
BVS Revenues are $512.3M
How Much Profit Does Bioventus's Make A Year?
BVS net income is -$156.2M

Is Bioventus Growing As A Company?

What Is Bioventus's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15%
What Is Bioventus's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Bioventus Stock Price Performance

Did Bioventus Stock Go Up Last Month?
Bioventus share price went down by -9.71% last month
Did BVS's Share Price Rise Over The Last Year?
BVS share price rose by 206.54% over the past 1 year

What Is Bioventus 52-Week High & Low?

What Is Bioventus’s 52-Week High Share Price?
Bioventus has traded as high as $14.38 over the past 52 weeks
What Is Bioventus’s 52-Week Low Share Price?
Bioventus has traded as low as $3.77 over the past 52 weeks

Bioventus Price To Free Cash Flow

Is Bioventus Stock Overvalued?
Bioventus is trading at a price to free cash flow ratio of 25.78
Is Bioventus Stock Undervalued?
Bioventus EV to Free Cash Flow ratio is 39.39
What Is Bioventus’s Price Earnings Growth Ratio?
BVS PEG ratio is 0.00
Is Bioventus Trading At A Premium To Earnings?
Bioventus EV to EBIT ratio is 0.00

Is It Risky To Buy Bioventus?

How Much Debt Does Bioventus Have?
Total long term debt quarterly is $383.6M
How Much Cash Does Bioventus Have?
Cash and short term investments quarterly total is $43.1M
What Is Bioventus’s Book Value Per Share?
Book value per share is 2.29

Is Bioventus Cash Flow Positive?

What Is BVS Cash Flow From Operations?
Cash flow from operations (TTM) is $29.8M
What Is Bioventus’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$11.7M
What Is Bioventus’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.7M

Bioventus Return On Invested Capital

Is Management Doing A Good Job?
BVS return on invested capital is -6.61%
What Is Bioventus Return On Assets?
ROA measures how assets are converting to revenues and is -4.96%
What Is BVS Return On Equity?
ROE is a measure of profitability and is -18.97%

Bioventus Earnings Date & Stock Price

What Is Bioventus's Stock Price Today?
A single share of BVS can be purchased today for 11.71
What Is Bioventus’s Stock Symbol?
Bioventus trades on the nasdaq under the ticker symbol: BVS
When Is Bioventus’s Next Earnings Date?
The next quarterly earnings date for Bioventus is scheduled on March 12, 2025
When Is BVS's next ex-dividend date?
Bioventus's next ex-dividend date is November 25, 2024
How To Buy Bioventus Stock?
You can buy Bioventus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Bioventus Competitors

Who Are Bioventus's Competitors?
Below is a list of companies who compete with Bioventus or are related in some way:
- Boston Scientific Corp (BSX)
- Perspective Therapeutics Inc (CATX)
- Insulet Corp (PODD)
- Catheter Precision Inc (VTAK)
- Xtant Medical Holdings Inc (XTNT)

Bioventus Dividend Yield

What Is BVS Dividend Yield?
Bioventus’s dividend yield currently is 0%
What Is Bioventus’s Payout Ratio?
Bioventus’s payout ratio is 0%
When Did Bioventus Last Pay A Dividend?
The latest dividend pay date is November 25, 2024
What Is Bioventus’s Dividend Per Share?
Bioventus pays a dividend of $0.00 per share

Bioventus Analyst Estimates

	YoY Growth	Past Surprise
EPS:	0%	296.83%
Revenue:	15.04%	4.3%

Analyst Recommendations

Buy Recommendations:	2
Hold Recommendations:	0
Sell Recommendations:	0
Price Target:	14.67
Upside from Last Price:	25.25%

Major Shareholders

How many BVS shares are owned by institutional investors?
72.6M BVS shares are owned by institutional investors
How many BVS shares are owned by insiders?
4.2M BVS shares are owned by insiders